--- title: "FOCUS PHARMACEUTICALS LIMITED — Ownership Dossier" canonical: https://whiteintel.dev/entity/0855265c-e49d-51b3-889c-a58281c9c315 json: https://whiteintel.dev/api/public/dossier/0855265c-e49d-51b3-889c-a58281c9c315 identifier: oo:GB-COH-04522142 jurisdiction: GB risk: Low source: WhiteIntel corporate-ownership graph --- # FOCUS PHARMACEUTICALS LIMITED **Type:** Company **Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb) **Identifier:** `oo:GB-COH-04522142` **Risk level:** Low **Canonical dossier:** https://whiteintel.dev/entity/0855265c-e49d-51b3-889c-a58281c9c315 **Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0855265c-e49d-51b3-889c-a58281c9c315 ## Ownership & control ### Owners / controllers - **The Blackstone Group Inc.** (beneficial owner) — 100% — https://whiteintel.dev/entity/127661b5-8626-5163-9d68-1c117d330029 - **The Blackstone Group Inc.** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/f082cef2-c25e-438b-8f42-94dfb1c218e7 - **MERCURY PHARMA GROUP LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/63e07956-8fd6-562b-a2f3-213d9b7c018f - **The Blackstone Group Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/127661b5-8626-5163-9d68-1c117d330029 - **The Blackstone Group Inc.** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/127661b5-8626-5163-9d68-1c117d330029 ### UBO chain (walk to the ultimate owner) A **12-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing. ## Company profile (live · UK Companies House) - **Company number:** `04522142` - **Status:** active - **Type:** ltd - **Incorporated:** 2002-08-30 - **Registered office:** Dashwood House, 69 Old Broad Street, London, EC2M 1QS, United Kingdom - **SIC:** 21200, 46460, 72190 ### Officers - [TMF CORPORATE ADMINISTRATION SERVICES LIMITED](https://whiteintel.dev/entity/c0373e15-d094-5410-ab4b-6b4d1de9edc7) — corporate secretary · appointed 2022-03-16 - IDRIS, Amaar Fainan — director · British · appointed 2025-02-06 - STICKLER, Andreas — director · German · appointed 2022-01-21 - GRETHE, Richard Paul — secretary · British · appointed 2004-12-01 · resigned 2014-10-01 - LEAVER, Linda — secretary · British · appointed 2002-10-28 · resigned 2003-10-01 - MAGINLEY, Bronson Raymond — secretary · British · appointed 2003-10-01 · resigned 2004-12-01 - SULLY, Robert — secretary · appointed 2018-10-01 · resigned 2022-03-16 - SULLY, Robert James — secretary · appointed 2014-10-01 · resigned 2016-12-31 - WILLIAMS, David Richard — secretary · appointed 2016-12-31 · resigned 2018-10-01 - FORM 10 SECRETARIES FD LTD — corporate nominee secretary · appointed 2002-08-30 · resigned 2002-09-17 - AHMAD, Adeel — director · Canadian · appointed 2016-01-08 · resigned 2022-01-31 - BEIGHTON, John — director · British · appointed 2014-10-01 · resigned 2016-12-31 - BROWN, Roland Alexander — director · British · appointed 2002-10-28 · resigned 2014-10-01 - CRESSWELL, Mark — director · British · appointed 2002-10-28 · resigned 2014-10-01 - DUNCAN, Graeme Neville — director · British · appointed 2018-11-30 · resigned 2022-01-12 - DUNCAN, Graeme Neville — director · British · appointed 2016-12-31 · resigned 2018-03-08 - GRETHE, Richard Paul — director · British · appointed 2004-12-01 · resigned 2014-10-01 - KAMATH, Vikram Laxman — director · British · appointed 2016-12-31 · resigned 2025-02-06 - LEAVER, Andrew Derrick — director · British · appointed 2002-10-28 · resigned 2007-10-19 - MAGINLEY, Bronson Raymond — director · British · appointed 2002-10-28 · resigned 2014-10-01 ### Beneficial owners (Persons with Significant Control) - [Mercury Pharma Group Limited](https://whiteintel.dev/entity/63e07956-8fd6-562b-a2f3-213d9b7c018f) — 75–100% shares · corporate PSC · United Kingdom — since 2021-12-16 - [Focus Pharma Holdings Limited](https://whiteintel.dev/entity/127661b5-8626-5163-9d68-1c117d330029) — 75–100% shares · corporate PSC · England — ceased 2021-12-16 - [The Blackstone Group Inc.](https://whiteintel.dev/entity/f082cef2-c25e-438b-8f42-94dfb1c218e7) — 25–50% shares · corporate PSC · United States — ceased 2021-06-01 - [Focus Pharma Holdings Limited](https://whiteintel.dev/entity/127661b5-8626-5163-9d68-1c117d330029) — 75–100% shares · corporate PSC · England — ceased 2020-03-27 ## Provenance - OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/04522142 - companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/04522142 ## Get the full, resolved dossier (agent-callable) The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent: ```bash npx -y @whiteintel/mcp-server # then: get_dossier · trace_ownership_path · check_offshore_exposure ``` Or unlock a one-off cited dossier for **FOCUS PHARMACEUTICALS LIMITED** — https://whiteintel.dev/entity/0855265c-e49d-51b3-889c-a58281c9c315 · pricing https://whiteintel.dev/pricing. --- _This is the markdown-for-agents view of the WhiteIntel dossier for **FOCUS PHARMACEUTICALS LIMITED**. Human view: https://whiteintel.dev/entity/0855265c-e49d-51b3-889c-a58281c9c315 · Structured JSON: https://whiteintel.dev/api/public/dossier/0855265c-e49d-51b3-889c-a58281c9c315._ _Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._